These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15103269)

  • 1. [The treatment of migraine by pharmacists: a French multicenter study].
    Lantéri-Minet M; Nachit-Ouinekh F; Mihout B; Slama A; El Hasnaoui A
    Rev Neurol (Paris); 2004 Apr; 160(4 Pt 1):441-6. PubMed ID: 15103269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-medication for migraine: A nationwide cross-sectional study in Italy.
    Brusa P; Allais G; Scarinzi C; Baratta F; Parente M; Rolando S; Gnavi R; Spadea T; Costa G; Benedetto C; Mana M; Giaccone M; Mandelli A; Manzoni GC; Bussone G
    PLoS One; 2019; 14(1):e0211191. PubMed ID: 30673780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine attacks in the pharmacy: a survey in Piedmont, Italy.
    Brusa P; Allais G; Bussone G; Rolando S; Giaccone M; Aguggia M; Benedetto C
    Neurol Sci; 2014 May; 35 Suppl 1():5-9. PubMed ID: 24867827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand.
    Saengcharoen W; Lerkiatbundit S
    Headache; 2013 Oct; 53(9):1451-63. PubMed ID: 23808927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey.
    Donnet A; Lantéri-Minet M; Aucoin F; Allaf B
    Headache; 2009 Jul; 49(7):1014-21. PubMed ID: 19486362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention, education and information: the role of the community pharmacist in the management of headaches.
    Giaccone M; Baratta F; Allais G; Brusa P
    Neurol Sci; 2014 May; 35 Suppl 1():1-4. PubMed ID: 24867826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine therapy: a survey of pharmacists' knowledge, attitudes, and practice patterns.
    Wenzel RG; Lipton RB; Diamond ML; Cady R
    Headache; 2005 Jan; 45(1):47-52. PubMed ID: 15663613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Vigimig study of naratriptan use in general practice].
    Lanteri-Minet M; Nachit-Ouinekh F; Druais PL; Allaert FA; El Hasnaoui A
    Presse Med; 2007 Nov; 36(11 Pt 1):1536-44. PubMed ID: 17664053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.
    MacGregor EA; Brandes J; Gendolla A; Giammarco R
    Curr Med Res Opin; 2004 Nov; 20(11):1777-83. PubMed ID: 15537478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.
    MacGregor EA; Brandes J; Eikermann A
    Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Migraine or headache management: a pharmacy survey].
    Desamericq G; Revol A; Laforest L; Chamba G; Bauguil G; Ritleng C; Van Ganse E
    Therapie; 2009; 64(6):395-403. PubMed ID: 20025843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan.
    Diener HC; Dowson A; Whicker S; Bacon T
    J Headache Pain; 2008 Dec; 9(6):359-65. PubMed ID: 18953489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is a migraine screener useful for pharmacists in community pharmacy to distinguish patients with migraine?].
    Ishii M; Nagamine A; Kimura Y; Imagawa A; Takahashi J; Hara H; Masuda Y; Usami S; Kiuchi Y
    Yakugaku Zasshi; 2010 Jun; 130(6):881-7. PubMed ID: 20519867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a survey tool assessing effectiveness of an educational intervention on the caring behaviors and referral activities of community pharmacists for migraineurs.
    O'Neal KS; Murray KA; Skomo ML; Carter SM; McConaha J
    Res Social Adm Pharm; 2015; 11(3):352-63. PubMed ID: 25483402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Migraine in general practice. A French multicenter study].
    Fabre N; Nachit-Ouinekh F; Becq JP; Chastan G; Sénard JM; El Hasnaoui A
    Rev Neurol (Paris); 2005 Oct; 161(10):949-56. PubMed ID: 16365624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists' interventions on prescription problems in one French community pharmacy: A prospective pilot study.
    Castronovo A; Gervais F; Mongaret C; Slimano F
    Ann Pharm Fr; 2018 Jul; 76(4):299-305. PubMed ID: 29555106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication patterns of recurrent headache sufferers: a community study.
    Forward SP; McGrath PJ; MacKinnon D; Brown TL; Swann J; Currie EL
    Cephalalgia; 1998 Apr; 18(3):146-51. PubMed ID: 9595208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.
    Hoffmann W; Herzog B; Mühlig S; Kayser H; Fabian R; Thomsen M; Cramer M; Fiss T; Gresselmeyer D; Janhsen K
    Ann Pharmacother; 2008 Dec; 42(12):1804-13. PubMed ID: 19001531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and medication preferences of individuals with headache presenting to a community pharmacy.
    Wenzel RG; Schommer JC; Marks TG
    Headache; 2004 Jan; 44(1):90-4. PubMed ID: 14979890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.